624P Belvarafenib in Patients (pts) with BRAF Class II or III Alteration-Positive Tumours: TAPISTRY Study R. Dziadziuszko,S. Damian, S. Gadgeel, E. Garralda, A. Italiano, J.E. Kim, M. Krzakowski, C-C. Lin,A. Popovtzer, D. Thomas, W. Kirschbrown, S. Patel, T. Pham, M. Sbirnac, F. Wu, F. BarlesiAnnals of Oncology（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
